Alliance addresses buy-side regulatory pressure

Microgen has teamed up with NumeriX and Independent Risk Monitoring to launch a Microgen Aptitude-based service to address the regulations arising from UCITS III, Mifid, and the increasing use of OTC derivatives in portfolios managed by buy-side firms. The solution - Microgen Independent Valuation and Risk (IVR) - is aimed at meeting the challenges facing asset managers and their service providers in relation to the increasing use of OTC derivative-based products. Microgen IVR provides an in